Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts

BACKGROUND: Patient preferences are key parameters to evaluate benefit-harm balance of statins for primary prevention but they are not readily available to guideline developers and decision makers. Our study aimed to elicit patient preferences for benefit and harm outcomes related to use of statins...

Descripción completa

Detalles Bibliográficos
Autores principales: Yebyo, Henock G., Aschmann, Hélène E., Yu, Tsung, Puhan, Milo A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960214/
https://www.ncbi.nlm.nih.gov/pubmed/29776337
http://dx.doi.org/10.1186/s12872-018-0838-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960214/
https://www.ncbi.nlm.nih.gov/pubmed/29776337
http://dx.doi.org/10.1186/s12872-018-0838-9

Ejemplares similares